Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-069525
Filing Date
2009-03-31
Accepted
2009-03-31 16:55:22
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 811165
2 FIRST AMENDMENT TO LEASE DATED DECEMBER 2003 dex1051.htm EX-10.5.1 22464
3 SECOND AMENDMENT TO LEASE DATED NOVEMBER 18, 2008 dex1052.htm EX-10.5.2 11000
4 THIRD AMENDMENT TO LEASE DATED MARCH 25, 2009 dex1053.htm EX-10.5.3 13659
5 CONSENT OF MOSS ADAMS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2257
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9327
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9367
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3275
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3298
  Complete submission text file 0001193125-09-069525.txt   887324
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

EIN.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15360 | Film No.: 09719764
SIC: 3841 Surgical & Medical Instruments & Apparatus